LinkedIn Profile

Access Second Sight Medical Products historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:eyes 53090 Apr 16th, 2020 12:00AM Second Sight Medical Products 8.6K 115.00 Open Medical Device Apr 15th, 2020 10:22PM Apr 15th, 2020 10:22PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 15th, 2020 12:00AM Second Sight Medical Products 8.6K 115.00 Open Medical Device Apr 14th, 2020 10:23PM Apr 14th, 2020 10:23PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 14th, 2020 12:00AM Second Sight Medical Products 8.6K 115.00 Open Medical Device Apr 14th, 2020 09:25AM Apr 14th, 2020 09:25AM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 13th, 2020 12:00AM Second Sight Medical Products 8.6K 115.00 Open Medical Device Apr 12th, 2020 10:23PM Apr 12th, 2020 10:23PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 12th, 2020 12:00AM Second Sight Medical Products 8.6K 115.00 Open Medical Device Apr 12th, 2020 03:12PM Apr 12th, 2020 03:12PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 11th, 2020 12:00AM Second Sight Medical Products 8.6K 117.00 Open Medical Device Apr 11th, 2020 02:51PM Apr 11th, 2020 02:51PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 10th, 2020 12:00AM Second Sight Medical Products 8.6K 120.00 Open Medical Device Apr 10th, 2020 02:15PM Apr 10th, 2020 02:15PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 9th, 2020 12:00AM Second Sight Medical Products 8.5K 122.00 Open Medical Device Apr 9th, 2020 12:13PM Apr 9th, 2020 12:13PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 8th, 2020 12:00AM Second Sight Medical Products 8.5K 126.00 Open Medical Device Apr 8th, 2020 10:22AM Apr 8th, 2020 10:22AM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products
nasdaq:eyes 53090 Apr 7th, 2020 12:00AM Second Sight Medical Products 8.6K 126.00 Open Medical Device Apr 7th, 2020 12:21PM Apr 7th, 2020 12:21PM Second Sight’s mission is to restore useful vision to the blind and visually impaired. Second Sight is the leader in neuromodulation devices to treat blindness, with the most advanced technology platform delivering groundbreaking artificial vision. The recognized leader in retinitis pigmentosa, the company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. Second Sight’s Argus II retinal prosthesis system is an FDA and CE approved device that delivers durable, useful vision to people with severe to profound retinitis pigmentosa (RP). • The Argus II has been implanted in over 300 patients worldwide, with proven durability beyond 10 years • The Argus II is the standard of care for patients with severe RP, with over 25 exclusive regional centers offering the technology across North America The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes. If you would like to learn more about Second Sight® Medical Products or the Argus® II Retinal Prosthesis System, you can reach us at (800)350-7060. Open Medical Device, vision loss, wearables, Retinitis Pigmentosa Open 12744 San Fernando Rd Los Angeles California US 91342 Second Sight Medical Products

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.